Literature DB >> 25448482

Kinases, tails and more: regulation of PTEN function by phosphorylation.

Rita Fragoso1, João T Barata2.   

Abstract

Phosphorylation regulates the conformation, stability, homo- and heterotypic protein interactions, localization, and activity of the tumor suppressor PTEN. From a simple picture, at the beginning of this millennium, recognizing that CK2 phosphorylated PTEN at the C-terminus and thereby impacted on PTEN stability and activity, research has led to a significantly more complex scenario today, where for instance GSK3, Plk3, ATM, ROCK or Src-family kinases are also gaining the spotlight in this evolving play. Here, we review the current knowledge on the kinases that phosphorylate PTEN, and on the impact that specific phosphorylation events have on PTEN function.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  C-terminal tail; C2 domain; CK2; GSK3; Kinases; PLK3; PTEN; Phosphorylation; Posttranslational modification; Src

Mesh:

Substances:

Year:  2014        PMID: 25448482     DOI: 10.1016/j.ymeth.2014.10.015

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  28 in total

1.  MicroRNA-21 promotes phosphatase gene and protein kinase B/phosphatidylinositol 3-kinase expression in colorectal cancer.

Authors:  Wei-Zhong Sheng; Yu-Sheng Chen; Chuan-Tao Tu; Juan He; Bo Zhang; Wei-Dong Gao
Journal:  World J Gastroenterol       Date:  2016-06-28       Impact factor: 5.742

Review 2.  The functions of tumor suppressor PTEN in innate and adaptive immunity.

Authors:  Lang Chen; Deyin Guo
Journal:  Cell Mol Immunol       Date:  2017-06-26       Impact factor: 11.530

Review 3.  Protein kinase CK2 in breast cancer: the CK2β regulatory subunit takes center stage in epithelial plasticity.

Authors:  Odile Filhol; Sofia Giacosa; Yann Wallez; Claude Cochet
Journal:  Cell Mol Life Sci       Date:  2015-05-20       Impact factor: 9.261

4.  Targeting casein kinase II restores Ikaros tumor suppressor activity and demonstrates therapeutic efficacy in high-risk leukemia.

Authors:  Chunhua Song; Chandrika Gowda; Xiaokang Pan; Yali Ding; Yongqing Tong; Bi-Hua Tan; Haijun Wang; Sunil Muthusami; Zheng Ge; Mansi Sachdev; Shantu G Amin; Dhimant Desai; Krishne Gowda; Raghavendra Gowda; Gavin P Robertson; Hilde Schjerven; Markus Muschen; Kimberly J Payne; Sinisa Dovat
Journal:  Blood       Date:  2015-07-28       Impact factor: 22.113

5.  Astrocyte Resilience to Oxidative Stress Induced by Insulin-like Growth Factor I (IGF-I) Involves Preserved AKT (Protein Kinase B) Activity.

Authors:  David Dávila; Silvia Fernández; Ignacio Torres-Alemán
Journal:  J Biol Chem       Date:  2015-12-02       Impact factor: 5.157

Review 6.  Phosphatidylinositol 3-phosphates-at the interface between cell signalling and membrane traffic.

Authors:  Andrea L Marat; Volker Haucke
Journal:  EMBO J       Date:  2016-02-17       Impact factor: 11.598

7.  RTK signaling requires C3ar1/C5ar1 and IL-6R joint signaling to repress dominant PTEN, SOCS1/3 and PHLPP restraint.

Authors:  Michael G Strainic; Elliot Pohlmann; Christopher C Valley; Ajay Sammeta; Wasim Hussain; Diane S Lidke; M Edward Medof
Journal:  FASEB J       Date:  2019-12-13       Impact factor: 5.191

8.  TRIM25 activates AKT/mTOR by inhibiting PTEN via K63-linked polyubiquitination in non-small cell lung cancer.

Authors:  Yuan-Ming He; Xiu-Min Zhou; Shuo-Yi Jiang; Zu-Bin Zhang; Bi-Yin Cao; Jin-Bao Liu; Yuan-Ying Zeng; Jun Zhao; Xin-Liang Mao
Journal:  Acta Pharmacol Sin       Date:  2021-04-30       Impact factor: 6.150

Review 9.  Protein kinase CK2: a potential therapeutic target for diverse human diseases.

Authors:  Christian Borgo; Claudio D'Amore; Stefania Sarno; Mauro Salvi; Maria Ruzzene
Journal:  Signal Transduct Target Ther       Date:  2021-05-17

Review 10.  Phosphatase and Tensin Homolog in Non-neoplastic Digestive Disease: More Than Just Tumor Suppressor.

Authors:  Tianyu He; Xiaoyun Zhang; Jianyu Hao; Shigang Ding
Journal:  Front Physiol       Date:  2021-06-01       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.